20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10406 | Tuvusertib | M1774,ATR inhibitor 1 | Apoptosis , ATM/ATR , Others , Chk |
Tuvusertib (M1774) is an orally available ataxia telangiectasia and Rad3-related (ATR) kinase inhibitor (Ki< 1 µΜ) with selective and potentially antitumor activity.Tuvusertib selectively inhibits ATR activity and blocks... | |||
T3032 | VE-821 | ATR Inhibitor IV | ATM/ATR |
VE-821 (ATR Inhibitor IV) is a selective ATP competitive inhibitor of ATR( Ki/IC50: 13/26 nM in cell-free assays). | |||
T62083 | Camonsertib | ATR inhibitor 4,RP-3500 | ATM/ATR |
Camonsertib (RP-3500) is a selective, orally active ATR kinase inhibitor (ATRi) with an IC50: 1.00 nM in biochemical assays and exhibits potent antitumour effects. Camonsertib is 30 times more selective for ATR than mTOR... | |||
T40077 | ATR-IN-9 | ||
ATR-IN-9 is a highly effective inhibitor of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). With an IC50 value as low as 10 nM, ATR-IN-9 demonstrates exceptional potency. | |||
T40212 | ATR-IN-4 | ||
ATR-IN-4, a potent inhibitor of ATR (Ataxia telangiectasia mutated gene Rad 3-associated kinase), restricts the growth of DU145 prostate cancer cells and NCI-H460 lung cancer cells, with IC 50 values of 130.9 nM and 41.3... | |||
T9321 | Zapnometinib | ATR-002,3,4-difluoro-2-(2-chloro-4-iodophenylaMino)-benzoic acid,PD0184264,2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic acid | Influenza Virus , MEK , Antibacterial |
Zapnometinib (ATR-002) is a MEK inhibitor. | |||
T62035 | ATR-IN-7 | ||
ATR-IN-7 is a potent inhibitor of ATR. | |||
T61636 | ATR-IN-19 | ||
ATR-IN-19 (Compound 15 R-configure) is an ATR inhibitor [1]. | |||
T63555 | ATR-IN-6 | ||
ATR-IN-6 is a potent inhibitor of ATR. ATR is a protein kinase that is involved in genome stability and DNA damage repair and is a member of the PIKK family. aTR-IN-6 has shown potential for ATR kinase-mediated diseases ... | |||
T62651 | ATR-IN-11 | ||
ATR-IN-11 (Compound Hit01) is a potent inhibitor of ataxia capillaris and Rad3-related (ATR) kinases. ATR-IN-11 is a promising lead compound for the discovery of subsequent drugs targeting the ATR kinase, a key regulator... | |||
T61587 | ATR-IN-15 | ||
ATR-IN-15 (compound 1) is a highly potent and orally active inhibitor of ATR kinase with an IC50 of 8 nM. Additionally, ATR-IN-15 demonstrates inhibitory activity against several targets, including human colon tumor cell... | |||
T79058 | ATR-IN-24 | ATM/ATR | |
ATR-IN-24 (Compound 1) is an ATR inhibitor with demonstrated anticancer activity [1]. | |||
T63923 | ATR-IN-5 | ||
ATR-IN-5 is a potent inhibitor of ATR, a member of the PIKK family of proteins involved in genome stability and DNA damage repair. ATR is a member of the PIKK family, a class of protein kinases involved in genome stabili... | |||
T62233 | ATR-IN-10 | ||
ATR-IN-10 is a potent and highly selective inhibitor of ATR kinase (IC50: 2.978 μM). | |||
T62548 | ATR-IN-17 | ||
ATR-IN-17 is a potent inhibitor of ATR kinase with good anti-cancer effects in LoVo cells (IC50: 1 nM). | |||
T61432 | ATR-IN-16 | ||
ATR-IN-16 (compound 46) is a highly effective ATR kinase inhibitor, exhibiting considerable anticancer activity in LoVo cells, as demonstrated by its IC 50 value of 410 nM [1]. | |||
T79121 | ATR-IN-29 | ATM/ATR | |
ATR-IN-29, a potent, orally active inhibitor of ATR kinase, exhibits an IC50 of 1 nM and demonstrates antiproliferative activity [1]. | |||
T79031 | ATR-IN-21 | ATM/ATR | |
ATR-IN-21, also known as compound 60, is a potent inhibitor of ATR, exhibiting an IC50 of less than 1000 nM [1]. | |||
T63604 | ATR-IN-18 | ||
ATR-IN-18 is an orally active ATR kinase inhibitor (IC50: 0.69 nM). aTR-IN-18 exhibited anti-proliferative effects in LoVo cells (IC50: 37.34 nM). aTR-IN-18 showed anti-tumor effects. | |||
T62084 | ATR-IN-8 | ||
ATR-IN-8 is a potent inhibitor of ATR. ATR-IN-8 has shown potential research value in cancer diseases. |